Menopausal hormone therapy and oral contraceptives have been associated with a reduced risk of glioma in a meta-analysis [10], thus, estrogen receptors have been suggested as a potential target in endocrine treatment of glioma [11]. The gene discussed is ESR1; the disease is glioma.